Strafford will be offering a webinar/teleconference on "Inducement to Infringe in Hatch-Waxman Litigation: Lessons from Commil USA v. Cisco Systems and Bayer Schering v. Lupin for Pharma Patents" on August 21, 2013 from 1:00 to 2:30 pm (EDT). Thomas L. Irving, Dr. David P. Frazier, and Robert F. Shaffer of Finnegan Henderson Farabow Garrett & Dunner provide patent counsel with guidance on claim and label language; to proactively coordinate patent, regulatory and clinical personnel; and to maintain consistency between claims and likely or actual label language throughout patent prosecution and label negotiation with the FDA. The webinar will review the following questions:
What can be learned from the AstraZeneca v. Apotex, Bayer Schering v.
Lupin, and Commil USA v. Cisco Systems Inc. decisions?
• What are the best approaches to maintain consistency between claims and likely or actual label language?
• What steps can be taken to maintain the coordination of patent, regulatory and clinical personnel throughout the patent prosecution and label negotiation with the FDA?
The registration fee for the webinar is $297 ($362 for registration and CLE processing). Those registering by July 26, 2013 will receive a $50 discount. Those interested in registering for the webinar, can do so here.